№ lp_1_2_24469
File format: docx Character count: 19325 File size: 240 KB
Note: Year
Topic: Haematological malignancies, diagnostic service
Document type: User Guide
Organization: Newcastle upon Tyne Hospitals NHS Foundation Trust
Target audience: Medical professionals, laboratory staff
Description: This document provides an overview of the services and procedures provided by the Northern England Haemato-Oncology Diagnostic Service (NEHODS), including contact information, sample requirements, and reporting systems.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Operational Policy NBT SIHMDS - Bristol Haemato-Oncology Diagnostic Service (BHODS)13-1D-101h
Year: 2010
Region / city: Bristol
Theme: Haematological malignancy diagnostics
Document type: Operational Policy
Organization / institution: North Bristol NHS Trust
Author: Dr. Alastair Whiteway
Target audience: Medical and scientific professionals
Period of validity: Ongoing
Approval date: Not specified
Date of changes: Not specified
Using Intelligent Liver Function Tests (iLFTs) to detect malignancy: a retrospective observational cohort study
Year: 2022
Region / City: NHS Tayside
Topic: Liver disease detection, Malignancy detection
Document Type: Retrospective Observational Cohort Study
Institution: NHS Tayside
Author: Not specified
Target Audience: Clinicians, Medical researchers
Period of Effect: April 2022 – July 2024
Date of Approval: Not specified
Date of Changes: Not specified
Protocol for the Examination of Specimens From Patients With Primary Gestational Trophoblastic Malignancy
Year: 2021
Region / City: Not specified
Theme: Pathology, Cancer Protocols
Document Type: Protocol
Institution: CAP (College of American Pathologists)
Author: Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO
Target Audience: Pathologists, Medical Professionals in Cancer Care
Effective Period: March 2022
Approval Date: November 2021
Last Revision Date: November 2021
Topics: NEHODSA Haemato-Oncology Malignancy